Skip to content
Screener

Halozyme Therapeutics HALO AOCI

AOCI at other companies

West Pharmaceutical Services logo
West Pharmaceutical ServicesWST
-$140.4M-58.3%
AMP
Amphastar PharmaceuticalsAMPH
-$5.9M-10.1%
AptarGroup logo
AptarGroupATR
-$198.72M+43.4%
Opko Health logo
Opko HealthOPK
-$28.39M-14.8%
Amneal Pharmaceuticals, Inc. logo
Amneal Pharmaceuticals, Inc.AMRX
-$100.67M-3.3%
Ionis Pharmaceuticals logo
Ionis PharmaceuticalsIONS
-$33.9M-21.1%

Other financials

Income statement

See full
Revenue$481.0M+47.7%
Gross profit$401.8M+43.8%
Operating income$287.7M+42.1%
Net income$229.9M+39.2%
EPS (diluted)$1.90+42.9%

Balance sheet

See full
Cash & equivalents$164.0M+165%
Total debt$2.2B+41.6%
Total equity$143.5M-56.9%
Total assets$2.6B+25.5%

Cash flow

See full
Operating cash flow$240.9M+142%
CapEx$4.2M+167%
Free cash flow$236.7M+141%

Valuation

See full
Market cap$9.91B+36.0%
Enterprise value$11.93B+36.1%
P/E13.8×-3.9×
P/S6×-0.2×

Profitability

See full
Gross margin82.4%-1.8pp
Operating margin59.3%+9.0pp
Net margin47.9%+6.5pp
FCF margin48.5%+2.6pp

Returns & leverage

See full
Return on equity124.5%+12.7pp
Debt / equity15.2×+10.6×
Current ratio2.7×-5.7×

Where this comes from

Reported directly by Halozyme Therapeutics in its filing.

Tagged under the XBRL concept us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax.

The source filing: Halozyme Therapeutics’s 10-Q, filed August 6, 2026. Open the filing →

Filed
Aug 6, 2026, 4:11 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001159036-26-000104

FAQ

What is Halozyme Therapeutics's AOCI?
Halozyme Therapeutics (HALO) reported AOCI of -$7.83M in Q2 2026.
How has Halozyme Therapeutics's AOCI changed year-over-year?
Halozyme Therapeutics's AOCI increased by 72.4% year-over-year, from -$28.4M to -$7.83M.
What is the long-term trend for Halozyme Therapeutics's AOCI?
Over 5 years (2020 to 2025), Halozyme Therapeutics's AOCI has grown at a 282.8% compound annual growth rate (CAGR), from $22K to -$18.09M.
What does AOCI mean?
Accumulated gains and losses bypassing the income statement — unrealized investment gains/losses, currency translation, pension adjustments, and hedge results.

Ask your AI about Halozyme Therapeutics's aoci.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude